L Landec Corp
L
Închisă
SectorConsumator defensiv
0
Rezumat
Modificarea prețului
24h
Minim
Maxim
Venit | -8.9M -15M |
|---|---|
Vânzări | -7.9M 23M |
Marjă de profit | -64.588 |
Angajați | 382 |
Recomandări | Puternic Cumpărare |
|---|---|
Prognoză pe 12 luni | +14.84% upside |
Următoarele câștiguri | 9 sept. 2026 |
|---|
Capitalizare de piață | 39M 178M |
|---|---|
Deschiderea anterioară | 0 |
Închiderea anterioară | 0 |
Sentimentul știrilor
By Acuity
50%
50%
51 / 131 Clasament în Consumer defensive
Landec Corp Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Despre Landec Corp
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.